Liven Pharmaceuticals Limited (PSX:LIVEN)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
65.96
-0.85 (-1.27%)
At close: Oct 1, 2025

Liven Pharmaceuticals Ratios and Metrics

Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
6,216110185152303133
Upgrade
Market Cap Growth
1406.66%-40.46%21.91%-49.80%127.48%83.37%
Upgrade
Enterprise Value
6,254349423387535359
Upgrade
Last Close Price
66.819.1115.3012.5525.0010.99
Upgrade
PB Ratio
6.94-0.82-1.51-1.38-3.16-1.63
Upgrade
P/TBV Ratio
7.24-----
Upgrade
EV/EBITDA Ratio
278.71-----
Upgrade
Debt / Equity Ratio
0.04-1.78-1.94-2.13-2.43-2.76
Upgrade
Debt / EBITDA Ratio
1.70-----
Upgrade
Quick Ratio
1.7600000
Upgrade
Current Ratio
3.760000.000
Upgrade
Return on Equity (ROE)
28.18%-----
Upgrade
Return on Assets (ROA)
-0.04%-6.86%-6.89%-7.20%-6.80%-6.82%
Upgrade
Return on Capital (ROIC)
-0.04%-7.84%-7.93%-8.35%-8.08%-8.12%
Upgrade
Earnings Yield
1.73%-10.12%-6.65%-9.39%-4.83%-12.70%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.